Genprex released FY2024 earnings on April 1, 2025 (EST), with actual revenue of USD 0 (forecast USD 0) and actual EPS of USD -266.953 (forecast USD -285)

Brief Summary

Genprex’s 2024 fiscal year financial report showed an EPS of -266.953 USD, beating the expected -285 USD, with actual revenue at 0 USD, as anticipated.

Impact of The News

1. Financial Performance Overview:

• Genprex reported an EPS of -266.953 USD, which is a slight improvement compared to the market’s expectation of -285 USD.
• The company reported zero revenue, aligning with market expectations.

2. Comparison with Industry Peers:

• The performance of Genprex, with no revenue and a significant negative EPS, suggests it is not on par with some peers in the broader technology and semiconductor sectors, such as TSMC, which reported a quarterly revenue of 331 billion USD and a growth of 10.1% due to demand for electronic products and AI chips .

3. Business Status and Future Trends:

• The absence of revenue and a large negative EPS indicate potential challenges in Genprex’s business model or market positioning.
• If the trend continues without strategic improvements or innovations, it may result in further financial difficulties.
• Without revenue generation, the company may struggle to sustain operations or attract investor interest unless significant changes or new sources of income are identified.